A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR (ECREST)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02687386 |
|
Recruitment Status :
Terminated
(Study medication no longer in production)
First Posted : February 22, 2016
Last Update Posted : February 14, 2022
|
Sponsor:
Dr David Ziegler
Collaborator:
Engeneic Pty Limited
Information provided by (Responsible Party):
Dr David Ziegler, Sydney Children's Hospitals Network
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | December 29, 2021 |
| Actual Study Completion Date : | December 29, 2021 |